It has, therefore, been suggested that selective COX-2 inhibitors of the inducible isoform may be free from renal adverse effects. Recent evidence suggests that this may not be so. Samir Malhotra ...

[1] These drugs are COX-1 sparing even at the highest ... choosing patients who might benefit from receiving highly selective COX-2 inhibitors until more data are available. There is no doubt ...

The drug's mechanism of action makes it particularly ... Both are types of NSAIDs, but they work differently. Celebrex is a ...

In fact, the risk may be associated with the entire class of COX-2 selective inhibitors, and an advisory committee of the US Food and Drug Administration (FDA) will meet in mid-February 2005 to ...